http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008502627-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
| filingDate | 2005-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008502627-A |
| titleOfInvention | Hydroxamates, their manufacture and use as pharmaceuticals |
| abstract | The object of the present invention is to provide compounds of formula (I), pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, preparation of the above compounds, drugs containing them and methods for their production, and The use of the above compounds in the control or prevention of diseases such as cancer. |
| priorityDate | 2004-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.